Cargando…
Oncolytic Virotherapy of Canine and Feline Cancer
Cancer is the leading cause of disease-related death in companion animals such as dogs and cats. Despite recent progress in the diagnosis and treatment of advanced canine and feline cancer, overall patient treatment outcome has not been substantially improved. Virotherapy using oncolytic viruses is...
Autores principales: | Gentschev, Ivaylo, Patil, Sandeep S., Petrov, Ivan, Cappello, Joseph, Adelfinger, Marion, Szalay, Aladar A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036544/ https://www.ncbi.nlm.nih.gov/pubmed/24841386 http://dx.doi.org/10.3390/v6052122 |
Ejemplares similares
-
Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients
por: Patil, Sandeep S, et al.
Publicado: (2012) -
Virotherapy of Canine Tumors with Oncolytic Vaccinia Virus GLV-1h109 Expressing an Anti-VEGF Single-Chain Antibody
por: Patil, Sandeep S., et al.
Publicado: (2012) -
Treatment of malignant effusion by oncolytic virotherapy in an experimental subcutaneous xenograft model of lung cancer
por: Weibel, Stephanie, et al.
Publicado: (2013) -
Vaccinia virus injected human tumors: oncolytic virus efficiency predicted by antigen profiling analysis fitted boolean models
por: Cecil, Alexander, et al.
Publicado: (2019) -
Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy
por: Adelfinger, Marion, et al.
Publicado: (2015)